Efficacy and safety of CAR-T cell therapy in B-ALL patients previously treated with blinatumomab

Saved in:
Bibliographic Details
Main Authors: Yurou Chu, Biqi Zhou, Rui Gao, Miao Miao, Huiying Qiu, Xiaowen Tang, Ying Wang, Suning Chen, Liqing Kang, Depei Wu, Yang Xu
Format: Article
Language:English
Published: Nature Publishing Group 2025-02-01
Series:Blood Cancer Journal
Online Access:https://doi.org/10.1038/s41408-025-01217-9
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823863259698036736
author Yurou Chu
Biqi Zhou
Rui Gao
Miao Miao
Huiying Qiu
Xiaowen Tang
Ying Wang
Suning Chen
Liqing Kang
Depei Wu
Yang Xu
author_facet Yurou Chu
Biqi Zhou
Rui Gao
Miao Miao
Huiying Qiu
Xiaowen Tang
Ying Wang
Suning Chen
Liqing Kang
Depei Wu
Yang Xu
author_sort Yurou Chu
collection DOAJ
format Article
id doaj-art-38f87b01a01c41a09da57a4def20f803
institution Kabale University
issn 2044-5385
language English
publishDate 2025-02-01
publisher Nature Publishing Group
record_format Article
series Blood Cancer Journal
spelling doaj-art-38f87b01a01c41a09da57a4def20f8032025-02-09T12:13:06ZengNature Publishing GroupBlood Cancer Journal2044-53852025-02-011511410.1038/s41408-025-01217-9Efficacy and safety of CAR-T cell therapy in B-ALL patients previously treated with blinatumomabYurou Chu0Biqi Zhou1Rui Gao2Miao Miao3Huiying Qiu4Xiaowen Tang5Ying Wang6Suning Chen7Liqing Kang8Depei Wu9Yang Xu10National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow UniversityNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow UniversityNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow UniversityNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow UniversityNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow UniversityNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow UniversityNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow UniversityNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow UniversityShanghai Unicar-Therapy Bio-medicine Technology Co., Ltd, Shanghai, China; Institute of Biomedical Engineering and Technology, Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, School of Chemistry and Molecular Engineering, East China Normal UniversityNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow UniversityNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow Universityhttps://doi.org/10.1038/s41408-025-01217-9
spellingShingle Yurou Chu
Biqi Zhou
Rui Gao
Miao Miao
Huiying Qiu
Xiaowen Tang
Ying Wang
Suning Chen
Liqing Kang
Depei Wu
Yang Xu
Efficacy and safety of CAR-T cell therapy in B-ALL patients previously treated with blinatumomab
Blood Cancer Journal
title Efficacy and safety of CAR-T cell therapy in B-ALL patients previously treated with blinatumomab
title_full Efficacy and safety of CAR-T cell therapy in B-ALL patients previously treated with blinatumomab
title_fullStr Efficacy and safety of CAR-T cell therapy in B-ALL patients previously treated with blinatumomab
title_full_unstemmed Efficacy and safety of CAR-T cell therapy in B-ALL patients previously treated with blinatumomab
title_short Efficacy and safety of CAR-T cell therapy in B-ALL patients previously treated with blinatumomab
title_sort efficacy and safety of car t cell therapy in b all patients previously treated with blinatumomab
url https://doi.org/10.1038/s41408-025-01217-9
work_keys_str_mv AT yurouchu efficacyandsafetyofcartcelltherapyinballpatientspreviouslytreatedwithblinatumomab
AT biqizhou efficacyandsafetyofcartcelltherapyinballpatientspreviouslytreatedwithblinatumomab
AT ruigao efficacyandsafetyofcartcelltherapyinballpatientspreviouslytreatedwithblinatumomab
AT miaomiao efficacyandsafetyofcartcelltherapyinballpatientspreviouslytreatedwithblinatumomab
AT huiyingqiu efficacyandsafetyofcartcelltherapyinballpatientspreviouslytreatedwithblinatumomab
AT xiaowentang efficacyandsafetyofcartcelltherapyinballpatientspreviouslytreatedwithblinatumomab
AT yingwang efficacyandsafetyofcartcelltherapyinballpatientspreviouslytreatedwithblinatumomab
AT suningchen efficacyandsafetyofcartcelltherapyinballpatientspreviouslytreatedwithblinatumomab
AT liqingkang efficacyandsafetyofcartcelltherapyinballpatientspreviouslytreatedwithblinatumomab
AT depeiwu efficacyandsafetyofcartcelltherapyinballpatientspreviouslytreatedwithblinatumomab
AT yangxu efficacyandsafetyofcartcelltherapyinballpatientspreviouslytreatedwithblinatumomab